Positron emission tomography to assess hypoxia and perfusion in lung cancer

doi:10.5306/wjco.v5.i5.824

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6703)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

367

WORD

252

HTML

3385

Figures (1-5)

151

Tables (1-3)

289

Sum=4444

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1082

Download

1177

Sum=2259

Dec 10, 2014 (publication date) through May 16, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Dec 10, 2014; 5(5): 824-844
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.824

Table 2 Hypoxia positron emission tomography tracer abbreviations

Abbreviation	Full name or chemical name
[*Cu]ATSM	[*Cu]-diacetyl-bis(N4-methylthiosemicarbazone)
[¹⁸F]EF1	2-(2-Nitroimidazol-1H-yl)-N-(3-[¹⁸F]fluoropropyl)acetamide
[¹⁸F]EF3	2-(2-Nitroimidazol-1H-yl)-N-(3,3,3-[¹⁸F]trifluoropropyl)acetamide
[¹⁸F]EF5	2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[¹⁸F]-pentafluoropropyl)-acetamide
[¹⁸F]FAZA	[¹⁸F]fluoroazomycin arabinoside
[¹⁸F]FETA	[¹⁸F]fluoroetanidazole
[¹⁸F]FETNIM	[¹⁸F]fluoroerythronitroimidazole
[¹⁸F]FMISO	[¹⁸F]fluoromisonidazole
[¹⁸F]FRP170	1-(2-[¹⁸F]fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole
[¹⁸F]FPIMO	[¹⁸F]pimonidazole
[¹⁸F]HX4	3-[¹⁸F]fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3,-triazol-1-yl)-propan-1-ol
[¹²⁴I]IAZA	[¹²⁴I]iodazomycin arabinoside
[¹²⁴I]IAZG	[¹²⁴I]iodazomycin galactoside

Citation: Verwer EE, Boellaard R, Veldt AAVD. Positron emission tomography to assess hypoxia and perfusion in lung cancer. World J Clin Oncol 2014; 5(5): 824-844
URL: https://www.wjgnet.com/2218-4333/full/v5/i5/824.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i5.824